Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.45M Buy
69,576
+11,286
+19% +$237K 0.11% 93
2024
Q4
$1.24M Sell
58,290
-11,490
-16% -$252K 0.09% 92
2024
Q3
$1.62M Buy
69,780
+22,505
+48% +$529K 0.11% 88
2024
Q2
$1.05M Buy
47,275
+9,060
+24% +$193K 0.09% 105
2024
Q1
$842K Buy
+38,215
New +$777K 0.07% 108

Other funds holding IX

Callan Capital's IX Position: Q1 2025 in Review

Callan Capital increased its ORIX (IX) stake by 19% in Q1 2025, buying an estimated $237K and bringing the position to 69,576 shares worth $1.45M. The position accounts for 0.11% of the portfolio, ranked #93.

Callan Capital first reported a position in IX in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.62M in Q3 2024. 191 funds tracked by Wall St. Rank hold IX as of Q1 2025.

  • Callan Capital held 69,576 shares of ORIX worth $1.45M as of Q1 2025.
  • Callan Capital bought 11,286 ORIX shares in Q1 2025, an estimated $237K.
  • ORIX made up 0.11% of Callan Capital's portfolio in Q1 2025, its #93 holding.
  • Callan Capital first reported a position in ORIX in Q1 2024 and has held it in 5 quarters since.
  • Callan Capital's ORIX position peaked at $1.62M in Q3 2024.
  • 191 funds tracked by Wall St. Rank held ORIX as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.